NCT06883565Completed
Tertiary Lymphoid Structures Related Genes Predicting Prognosis in Clear Cell Renal Cell Carcinoma: a Retrospective Cohort Study
Source: ClinicalTrials.gov · Last updated 19 Mar 2025
Brief summary (registry, in English)
The purpose of this research was to uncover the prognostic significance of tertiary lymphoid structures related genes from ccRCC patients with respect to clinical characteristics and outcomes. This offers a novel perspective on selecting populations for prostate cancer immunotherapy in future scenarios.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 232 (actual)
- First submitted
- 13 Mar 2025
- Start date
- 1 Jun 2024
- Primary completion date
- 31 Jan 2025
- Lead sponsor
- Ding-Wei Ye
- Diseases
- Kidney cancer, Childhood cancers
- NCT number
- NCT06883565
What you commit to
- Study type: Observational
- Participants enrolled: 232
- From 1 Jun 2024 to the primary completion date, 31 Jan 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- incomplete medical records, inadequate follow-up information, and confirmed non-prostatic acinar adenocarcinoma
Who the study is looking for
- patients diagnosed with renal cell carcinoma
Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fudan University Shanghai Cancer Center Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.